Cited by 892Cancer Cells and MetastasisAcute Lymphoblastic Leukemia researchDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Environment-mediated drug resistance: a major contributor to minimal residual disease

Meads, Mark B., Gatenby, Robert A., Dalton, William S.·2009·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Environment-mediated drug resistance is a form of de novo drug resistance that protects tumour cells from the initial effects of diverse therapies. Surviving foci of residual disease can then develop complex and permanent acquired resistance in response to the selective pressure of therapy. Recent evidence indicates that environment-mediated drug resistance arises from an adaptive, reciprocal signalling dialogue between tumour cells and the surrounding microenvironment. We propose that new therapeutic strategies targeting this interaction should be applied during initial treatment to prevent the emergence of acquired resistance.

Integrity signals

Registry

Crossref · 10.1038/nrc2714

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Treatment of Acute Lymphoblastic Leukemia
Pui, C., & Evans, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052603 · Cited by 2,012
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801479 · Cited by 1,899
Stromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G. W., Davé, S. S., Xiao, W., Powell, J. I., Zhao, H., Xu, W., Tan, B. T., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,847
Stimulation of Bone Formation in Vitro and in Rodents by Statins
Mundy, G. R., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B. F., Zhao, M., & Gutierrez, G. (1999) · Science · doi:10.1126/science.286.5446.1946 · Cited by 1,776
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Ömeroğlu, G., Meterissian, S. H., Ömeroğlu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,707
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Self-citation
Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies
Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., & Bissell, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.231 · Cited by 1,483
A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer
Braun, S., Vogl, F. D., Naume, B., Janni, W., Osborne, M. P., Coombes, R. C., Schlimok, G., Diel, I., Gerber, B., Gebauer, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050434 · Cited by 1,380
DQIS — Distributed Quorum-Based Independent Immune Surveillance: A Theoretical Framework for Byzantine Fault Tolerance for Multi-Channel Immune Surveillance
DQIS Research Group (2026) · PubMed · doi:10.5281/zenodo.21937949 · Cited by 1,333

Show all 109 references

Research works printed but not linked: 1

Goldie, J. H. & Coldman, A. J. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep. 63, 1727–1733 (1979).

Sorted by citations

Items 301–400 of 892

Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals
Xie, H., Li, C., Dang, Q., Chang, L. S., & Li, L. (2016) · Oncotarget · doi:10.18632/oncotarget.6372 · Cited by 49
Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment
Chen, C., Cheng, C.-T., Yuan, Y., Zhai, J., Arif, M., Fong, L. W. R., Wu, R., & Ann, D. K. (2015) · Oncotarget · doi:10.18632/oncotarget.3827 · Cited by 52
Upregulation of Drug Transporter Expression by Osteopontin in Prostate Cancer Cells
Hsieh, I., Huang, W.-H., Liou, H., Chuang, W., Yang, R., & Fu, W. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.082339 · Cited by 49
Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy
Taeb, S., Ashrafizadeh, M., Zarrabi, A., Rezapoor, S., Musa, A. E., Farhood, B., & Najafi, M. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009622666211224154952 · Cited by 49
Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression
Maiso, P., Mogollón, P., Ocio, E. M., & Garayoa, M. (2021) · Cancers · doi:10.3390/cancers13112542 · Cited by 48
Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment
Alsaed, B., Lin, L., Son, J., Li, J., Smolander, J., Lopez, T., Eser, P. Ö., Ogino, A., Ambrogio, C., Eum, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55378-5 · Cited by 51
Resveratrol Downregulates Interleukin-6-Stimulated Sonic Hedgehog Signaling in Human Acute Myeloid Leukemia
Su, Y., Li, S.-C., Wu, Y.-C., Wang, L., Chao, K. S. C., & Liao, H. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/547430 · Cited by 48
Retracted
Lysophospholipids secreted by splenic macrophages induce chemotherapy resistance via interference with the DNA damage response
Houthuijzen, J. M., Daenen, L. G. M., Roodhart, J. M. L., Oosterom, I., van Jaarsveld, M. T. M., Govaert, K. M., Smith, M. E., Sadatmand, S. J., Rosing, H., Kruse, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms6275 · Cited by 48
The bed and the bugs: Interactions between the tumor microenvironment and cancer stem cells
Castaño, Z., Brainson, C. F., Kim, C. F., & McAllister, S. S. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.006 · Cited by 50
The bone marrow niche in support of breast cancer dormancy
Walker, N. D., Patel, J. S., Munoz, J. L., Hu, M. D., Guiro, K., Sinha, G., & Rameshwar, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.033 · Cited by 47
Mini-pillar array for hydrogel-supported 3D culture and high-content histologic analysis of human tumor spheroids
Kang, J., Lee, D. W., Hwang, H. J., Yeon, S.-E., Lee, M., & Kuh, H. (2016) · Lab on a Chip · doi:10.1039/c6lc00526h · Cited by 46
Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia
Ganesan, S., Palani, H. K., Lakshmanan, V., Balasundaram, N., Alex, A. A., David, S., Venkatraman, A., Korula, A., George, B., Balasubramanian, P., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1964-8 · Cited by 48
Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy
Liu, X., Baer, J. M., Stone, M. L., Knolhoff, B. L., Hogg, G. D., Turner, M. C., Kao, Y., Weinstein, A. G., Ahmad, F. F., Chen, J., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.ado2402 · Cited by 48
Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells
Sakata, J., Utsumi, F., Suzuki, S., Niimi, K., Yamamoto, E., Shibata, K., Senga, T., Kikkawa, F., & Kajiyama, H. (2017) · Oncotarget · doi:10.18632/oncotarget.20107 · Cited by 47
The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues
Sebestyén, A. R., Dankó, T., Sztankovics, D., Moldvai, D., Raffay, R. E., Cervi, C., Krencz, I., Zsiros, V., Jeney, A., & Petővári, G. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10006-2 · Cited by 48
FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma
Lubrano, S., Cervantes‐Villagrana, R. D., Faraji, F., Ramirez, S. I., Sato, K., Adame-Garcia, S. R., Officer, A., Arang, N., Rigiracciolo, D. C., Quiroz, P. Y. A., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.02.001 · Cited by 51
Canonical Wnt Pathway Inhibitor ICG-001 Induces Cytotoxicity of Multiple Myeloma Cells in Wnt-Independent Manner
Grigson, E. R., Ozerova, M., Pisklakova, A., Liu, H., Sullivan, D. M., & Nefedova, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117693 · Cited by 46
STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody
Lee, J. S., Kang, J.-H., Boo, H., Hwang, S.-J., Hong, S., Lee, S.-C., Park, Y.-J., Chung, T.-M., Youn, H., Lee, S. M., et al. (2015) · Nature Communications · doi:10.1038/ncomms9499 · Cited by 46
Cell signaling heterogeneity is modulated by both cell-intrinsic and -extrinsic mechanisms: An integrated approach to understanding targeted therapy
Kim, E., Kim, J., Smith, M. A., Haura, E. B., & Anderson, A. R. A. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2002930 · Cited by 44
Exosome: a novel mediator in drug resistance of cancer cells.
Zhang, H.-D., Jiang, L.-H., Hou, J.-C., Zhong, S., Zhu, L.-P., Wang, D.-D., Zhou, S., Yang, S.-J., Wang, J., Zhang, Q., et al. (2018) · Epigenomics · doi:10.2217/epi-2017-0151 · Cited by 41
The mesenchymal tumor microenvironment
Cukierman, E., & Bassi, D. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20210 · Cited by 45
Miniaturized pre-clinical cancer models as research and diagnostic tools
Håkanson, M., Cukierman, E., & Charnley, M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.010 · Cited by 47
Metronomic Scheduling of Anticancer Treatment: The Next Generation of Multitarget Therapy?
André, N., Padovani, L., & Pasquier, E. (2011) · Future Oncology · doi:10.2217/fon.11.11 · Cited by 44
Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance
Zhang, Y., Zeng, S., Ma, J., Deng, G., Qu, Y., Guo, C., & Shen, H. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0387-y · Cited by 46
TGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC
Song, Y., Kim, J.-S., Choi, E. K., Kim, J., Kim, K. M., & Seo, H. R. (2017) · Oncotarget · doi:10.18632/oncotarget.15521 · Cited by 47
A 3D‐Bioprinted Multiple Myeloma Model
Wu, D., Wang, Z., Li, J., Song, Y. Y., Pérez, M. E. M., Wang, Z., Cao, X., Cao, C., Maharjan, S., Anderson, K. C., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100884 · Cited by 47
3D Versus 2D Cell Culture
Hess, M. W., Pfaller, K., Ebner, H. L., Beer, B., Hekl, D., & Seppi, T. (2010) · Methods in cell biology · doi:10.1016/s0091-679x(10)96027-5 · Cited by 46
Targeted ovarian cancer treatment: the TRAILs of resistance.
Goncharenko-Khaider, N., Lane, D. A., Matte, I., Rancourt, C., & Piché, A. (2012) · Europe PMC (PubMed Central) · Cited by 44
Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance
de Haart, S. J., Holthof, L. C., Noort, W. A., Minnema, M. C., Emmelot, M. E., Aarts‐Riemens, T., Doshi, P. D., Sasser, K., Yuan, H., de Bruijn, J. D., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.139667 · Cited by 44
A Carboxyl-Terminated Dendrimer Enables Osteolytic Lesion Targeting and Photothermal Ablation of Malignant Bone Tumors
Yang, Y., Gao, X., Zhang, S., Wang, Y., Zhou, Z., Xiao, J., Zhang, Q., & Cheng, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b15827 · Cited by 44
Exosome mediated multidrug resistance in cancer.
Yousafzai, N. A., Wang, H., Wang, Z., Zhu, Y., Zhu, L., Jin, H., & Wang, X. (2018) · Europe PMC (PubMed Central) · Cited by 44
Overcoming the diverse mechanisms of multidrug resistance in lung cancer cells by photodynamic therapy using pTHPP-loaded PLGA-lipid hybrid nanoparticles
Pramual, S., Lirdprapamongkol, K., Jouan–Hureaux, V., Barberi‐Heyob, M., Frochot, C., Svasti, J., & Niamsiri, N. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.02.012 · Cited by 44
Ancient hot and cold genes and chemotherapy resistance emergence
Wu, A. Y., Zhang, Q., Lambert, G., Khin, Z. P., Gatenby, R. A., Kim, H. J., Pourmand, N., Bussey, K. J., Davies, P. C. W., Sturm, J. C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512396112 · Cited by 43
Self-citation
Liver protects metastatic prostate cancer from induced death by activating E‐cadherin signaling
Ma, B., Wheeler, S., Clark, A. M., Whaley, D., Yang, M. H., & Wells, A. H. (2016) · Hepatology · doi:10.1002/hep.28755 · Cited by 43
Exosomes in head and neck cancer: Roles, mechanisms and applications
Cao, J., Zhang, M., Xie, F., Lou, J., Zhou, X., Zhang, L., Fang, M., & Zhou, F. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.005 · Cited by 43
Breast cancer patient‐derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments
Leiva, M. C., Garré, E., Gustafsson, A., Svanström, A., Bogestål, Y. R., Håkansson, J., Ståhlberg, A., & Landberg, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30191 · Cited by 42
Cancer‐associated fibroblasts secrete hypoxia‐induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway
Xie, J., Qi, X., Wang, Y., Yin, X., Xu, W., Han, S., Cai, Y., & Han, W. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00592-2 · Cited by 43
Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology
Brown, Y., Hua, S., & Tanwar, P. S. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.02.004 · Cited by 47
Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer
Yeh, W., Tsai, C., & Chen, D. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0630-2 · Cited by 42
Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence
Heydt, Q., Xintaropoulou, C., Clear, A. J., Austin, M. J., Pislariu, I., Miraki‐Moud, F., Cutillas, P. R., Korfi, K., Calaminici, M., Cawthorn, W. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25540-4 · Cited by 43
(5R)-5-hydroxytriptolide (LLDT-8), a novel immunosuppressant in clinical trials, exhibits potent antitumor activity via transcription inhibition
Wang, L., Xu, Y., Li, F., Li, Y., & Lou, L. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.004 · Cited by 42
Spatial and Functional Heterogeneities Shape Collective Behavior of Tumor-Immune Networks
Wells, D. K., Chuang, Y., Knapp, L. M., Brockmann, D., Kath, W. L., & Leonard, J. N. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004181 · Cited by 42
Inhibitors of Na+/K+ ATPase exhibit antitumor effects on multicellular tumor spheroids of hepatocellular carcinoma
Song, Y., Lee, S., Kim, S., Choi, I., Kim, S.-H., Shum, D., Heo, J., Kim, A., Kim, K. M., & Seo, H. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-62134-4 · Cited by 40
The Recent Advance of Cell-Penetrating and Tumor-Targeting Peptides as Drug Delivery Systems Based on Tumor Microenvironment
Zhang, Q., Liu, N., Wang, J., Liu, Y., Wang, K., Zhang, J., & Pan, X. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00629 · Cited by 48
ALK in cancer: from function to therapeutic targeting
Voena, C., Ambrogio, C., Iannelli, F., & Chiarle, R. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00797-9 · Cited by 49
Ready player one? Autophagy shapes resistance to photodynamic therapy in cancers
Duan, X., Chen, B., Cui, Y., Zhou, L., Wu, C., Yang, Z., Wen, Y., Miao, X., Li, Q., Xiong, L., et al. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1489-0 · Cited by 43
Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance
Park, E., Chen, J., Moore, A., Mangolini, M., Santoro, A., Boyd, J. R., Schjerven, H., Ecker, V., Buchner, M., Williamson, J. C., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax9340 · Cited by 38
Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology
Valcz, G., Sípos, F., Tulassay, Z., Molnar, B. A., & Yagi, Y. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202561 · Cited by 43
The role of spatial variations of abiotic factors in mediating intratumour phenotypic heterogeneity
Lorenzi, T., Venkataraman, C., Lorz, A., & Chaplain, M. A. J. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.05.002 · Cited by 38
A short update on cancer chemoresistance
Hamilton, G., & Rath, B. (2014) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-014-0311-z · Cited by 38
Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications
Hochheuser, C., Windt, L. J., Kunze, N. Y., de Vos, D., Tytgat, G. A. M., Voermans, C., & Timmerman, I. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0142 · Cited by 37
Rational nanocarrier design towards clinical translation of cancer nanotherapy
Guo, D., Ji, X., & Luo, J. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe35a · Cited by 39
Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation
Zhang, H., Wang, M., & Xu, Y. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0547 · Cited by 41
Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma
Sweeney, P. L., Suri, Y., Basu, A., Koshkin, V. S., & Desai, A. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.89 · Cited by 40
Inhibition of Midkine Suppresses Prostate Cancer CD133 + Stem Cell Growth and Migration
Erdoğan, S., Doğanlar, Z. B., Doğanlar, O., Turkekul, K., & Serttas, R. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.04.019 · Cited by 37
Integrating Models to Quantify Environment-Mediated Drug Resistance
Picco, N., Sahai, E. A., Maini, P. K., & Anderson, A. R. A. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0835 · Cited by 38
Chinese Herbal Medicine Wenxia Changfu Formula Reverses Cell Adhesion-Mediated Drug Resistance via the Integrin β1-PI3K-AKT Pathway in Lung Cancer
Zhang, Y., Wu, Z., Yu, H., Wang, H., Liu, G., Wang, S., & Ji, X. (2019) · Journal of Cancer · doi:10.7150/jca.25163 · Cited by 37
The Use of Porous Scaffold as a Tumor Model
Zhang, M., Boughton, P. C., Rose, B. R., Lee, C. S., & Hong, A. (2013) · International Journal of Biomaterials · doi:10.1155/2013/396056 · Cited by 37
A Digest on the Role of the Tumor Microenvironment in Gastrointestinal Cancers
Augsten, M., Hägglöf, C., Peña, C., & Östman, A. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0040-9 · Cited by 38
Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia
Ganesan, S., Alex, A. A., Chendamarai, E., Balasundaram, N., Palani, H. K., David, S., Kulkarni, U. P., Aiyaz, M., Mugasimangalam, R. C., Korula, A., et al. (2016) · Leukemia · doi:10.1038/leu.2016.227 · Cited by 35
Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies
Diazzi, S., Tartare‐Deckert, S., & Deckert, M. (2020) · Cancers · doi:10.3390/cancers12061364 · Cited by 44
Glutathione S-transferases P1-mediated interleukin-6 in tumor-associated macrophages augments drug-resistance in MCF-7 breast cancer
Dong, X., Sun, R., Wang, J., Yu, S.-Z., Cui, J., Guo, Z., Pan, X., Sun, J. T., Yang, J., & Pan, L. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114289 · Cited by 37
Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage
Cui, X., Wang, Q., Zhou, J., Wang, Y., Xu, C., Tong, F., Wang, H., & Kang, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.710695 · Cited by 38
Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies
Daenen, L. G. M., Houthuijzen, J. M., Cirkel, G. A., Roodhart, J. M. L., Shaked, Y., & Voest, E. E. (2013) · Oncogene · doi:10.1038/onc.2013.94 · Cited by 36
Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma
Kittirat, Y., Suksawat, M., Thongchot, S., Padthaisong, S., Phetcharaburanin, J., Wangwiwatsin, A., Klanrit, P., Sangkhamanon, S., Titapun, A., Loilome, W., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.897368 · Cited by 35
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer
Lee, J. E., Lee, P., Yoon, Y., Han, B. S., Ko, S., Park, M. S., Lee, Y. J., Kim, S. E., Cho, Y. J., Lim, J. H., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114716 · Cited by 38
Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling
Raudenská, M., Balvan, J., Hánělová, K., Bugajová, M., & Masařík, M. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188940 · Cited by 37
Targeting the tumour cell surface in advanced prostate cancer
Boixareu, C., Taha, T., Venkadakrishnan, V. B., Bono, J. S. D., & Beltran, H. (2025) · Nature Reviews Urology · doi:10.1038/s41585-025-01014-w · Cited by 43
Stromal CYR 61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia
Long, X., Yu, Y., Perlaky, L., Man, T., & Redell, M. S. (2015) · British Journal of Haematology · doi:10.1111/bjh.13492 · Cited by 35
Mesenchymal stem cells contribute to the chemoresistance of hepatocellular carcinoma cells in inflammatory environment by inducing autophagy
Han, Z., Jing, Y., Xia, Y., Zhang, S., Hou, J., Meng, Y., Yu, F., Liu, X., Wu, M., Zhang, P., et al. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-22 · Cited by 35
Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review)
Krishnan, S. R., Jaiswal, R., Brown, R. D., Luk, F., & Bebawy, M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3516 · Cited by 36
High-content imaging assays on a miniaturized 3D cell culture platform
Joshi, P., Datar, A., Yu, K., Kang, S., & Lee, M. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.02.014 · Cited by 36
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy
Gelfo, V., Mazzeschi, M., Grilli, G., Lindzen, M., Santi, S., D’Uva, G., Győrffy, B., Ardizzoni, A., Yarden, Y., & Lauriola, M. (2018) · Cancers · doi:10.3390/cancers10100355 · Cited by 36
EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer
Xiao, Z., Liu, Y., Li, Q., Liu, Q., Liu, Y., Luo, Y., & Wei, S. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04348-5 · Cited by 35
Gefitinib inhibits the cross‐talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity
Borghese, C., Cattaruzza, L., Pivetta, E., Normanno, N., Luca, A. D., Mazzucato, M., Celegato, M., Colombatti, A., & Aldinucci, D. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24456 · Cited by 35
The Membrane-Proximal KXGFFKR Motif of α-Integrin Mediates Chemoresistance
Liu, C.-C., Leclair, P., Yap, S. Q., & Lim, C. J. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00580-13 · Cited by 35
Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine
Schwark, K., Messinger, D., Cummings, J. R., Bradin, J., Kawakibi, A. R., Babila, C. M., Lyons, S., Ji, S., Cartaxo, R. T., Kong, S., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.922928 · Cited by 35
Nanotechnology-based delivery systems to overcome drug resistance in cancer
Patel, H. H., Li, J., Bo, L., Mehta, R., Ashby, C. R., Wang, S., Cai, W., & Chen, Z. (2024) · Medical Review · doi:10.1515/mr-2023-0058 · Cited by 38
Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support
Boutter, J., Huang, Y., Marovca, B., Vonderheit, A., Grotzer, M. A., Eckert, C., Cario, G., Wollscheid, B., Horváth, P., Bornhauser, B. C., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2572 · Cited by 35
Mechanisms of Matrix-Induced Chemoresistance of Breast Cancer Cells—Deciphering Novel Potential Targets for a Cell Sensitization
Jakubzig, B., Baltes, F., Henze, S., Schlesinger, M., & Bendas, G. (2018) · Cancers · doi:10.3390/cancers10120495 · Cited by 36
Reconciling environment-mediated metabolic heterogeneity with the oncogene-driven cancer paradigm in precision oncology
Linden, C. V., & Corbet, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.016 · Cited by 34
Resistance Mechanisms of Anti-angiogenic Therapy and Exosomes-Mediated Revascularization in Cancer
Zeng, Y., & Fu, B. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.610661 · Cited by 35
Organoids in cancer research: a review for pathologist‐scientists
Wood, L. D., & Ewald, A. J. (2021) · The Journal of Pathology · doi:10.1002/path.5684 · Cited by 35
The Advancing Roles of Exosomes in Breast Cancer
Wang, X., Sun, C., Huang, X., Li, J., Fu, Z., Li, W., & Yin, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.731062 · Cited by 35
Leukemia cell mobilization with G-CSF plus plerixafor during busulfan–fludarabine conditioning for allogeneic stem cell transplantation
Konopleva, M. V., Benton, C. B., Thall, P. F., Zeng, Z., Shpall, E. J., Ciurea, S. H., Kebriaei, P., Alousi, A. M., Popat, U., Anderlini, P. N., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.58 · Cited by 34
CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model
Domańska, U., Boer, J. C., Timmer‐Bosscha, H., van Vugt, M. A. T. M., Hoving, H. D., Kliphuis, N. M., Rosati, S., van der Poel, H. G., de Jong, I. J., de Vries, E. G. E., et al. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9673-2 · Cited by 34
Game theory in the death galaxy: interaction of cancer and stromal cells in tumour microenvironment
Wu, A. Y., Liao, D., Tlsty, T. D., Sturm, J. C., & Austin, R. H. (2014) · Interface Focus · doi:10.1098/rsfs.2014.0028 · Cited by 34
Bone Marrow Stroma-Induced Transcriptome and Regulome Signatures of Multiple Myeloma
Dziadowicz, S. A., Wang, L., Akhter, H., Aesoph, D., Sharma, T., Adjeroh, D., Hazlehurst, L., & Hu, G. (2022) · Cancers · doi:10.3390/cancers14040927 · Cited by 33
A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer
Berdiel‐Acer, M., Berenguer, A., Pamplona, R. S., Cuadras, D., Sanjuán, X., Paúles, M. J., Santos, C., Salazar, R., Moreno, V. R., Capellá, G., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2237 · Cited by 34
Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β1-Integrin Emerges as a Key Factor for Breast Cancer Chemosensitization upon Collagen Type 1 Binding
Baltes, F., Caspers, J., Henze, S., Schlesinger, M., & Bendas, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144956 · Cited by 33
Targeting tumor-associated macrophages with STING agonism improves the antitumor efficacy of osimertinib in a mouse model of EGFR-mutant lung cancer
Lin, Z., Wang, Q., Jiang, T., Wang, W., & Zhao, J. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1077203 · Cited by 33
Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment
Abdi, J., Qiu, L., & Chang, H. (2014) · Biomarker Research · doi:10.1186/2050-7771-2-10 · Cited by 33
Challenges and prospects in HER2-positive breast cancer-targeted therapy
Li, X., Zhang, X., Yin, S., & Nie, J. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104624 · Cited by 39
Extracellular Matrix Proteins Modulate Antimigratory and Apoptotic Effects of Doxorubicin
Said, G., Guilbert, M., Morjani, H., Garnotel, R., Jeannesson, P., & Btaouri, H. E. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/268681 · Cited by 32
Cancer stem cell and stromal microenvironment.
Li, L., COLE, J. T., & Margolin, D. A. (2013) · Europe PMC (PubMed Central) · Cited by 32
Role of extracellular signal-regulated kinase (ERK)1/2 in multicellular resistance to docetaxel in MCF-7 cells
Kang (2010) · International Journal of Oncology · doi:10.3892/ijo_00000714 · Cited by 32
Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents
Doğanlar, O., Doğanlar, Z. B., Kurtdere, A. K., Chasan, T., & Ok, E. S. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110940 · Cited by 33
Understanding the implications of co-delivering therapeutic agents in a nanocarrier to combat multidrug resistance (MDR) in breast cancer
Fulfager, A., & Yadav, K. S. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102405 · Cited by 32
MRE11 as a molecular signature and therapeutic target for cancer treatment with radiotherapy
Wang, Y., Hung, A. C., Lo, S. J., Hsieh, Y.-C., & Yuan, S. F. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.013 · Cited by 33
Iron participated in breast cancer chemoresistance by reinforcing IL-6 paracrine loop
Li, J., He, K., Liu, P., & Xu, L. X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.064 · Cited by 32

Authors: Meads, M. B., Gatenby, R. A., & Dalton, W. S.
Affiliations: Moffitt Cancer Center (US)
Corresponding author: Dalton, William S.
ORCID: Meads, Mark B.
Gatenby, Robert A.
Dalton, William S.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2009-08-20
Volume: 9
Issue: 9
Pages: 665-674
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2714
OpenAlex: W2066616821
Cited by: 892
References: 109
Citations by year: 2026: 33 · 2025: 44 · 2024: 35 · 2023: 55 · 2022: 54 · 2021: 74 · 2020: 65 · 2019: 58 · 2018: 56 · 2017: 52 · 2016: 68 · 2015: 61 · 2014: 64 · 2013: 51 · 2012: 52
FWCI: 3.53
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: tumor microenvironment, minimal residual disease, recurrence, acquired drug resistance, stromal factors, adjuvant therapy, cancer therapy resistance
MeSH terms: Humans, Neoplasms, Signal Transduction, Stromal Cells, Neoplasm, Residual, Drug Resistance, Neoplasm

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Environment-mediated drug resistance: a major contributor to minimal residual disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks